# Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome

> **NCT06560294** · NA · RECRUITING · sponsor: **Tanta University** · enrollment: 40 (estimated)

## Conditions studied

- Glue Embolization
- Pelvic Congestion Syndrome

## Interventions

- **DRUG:** Micronized purified flavonoid fraction (Daflon ®)
- **OTHER:** Glue embolization

## Key facts

- **NCT ID:** NCT06560294
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-17
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06560294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06560294, "Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06560294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*